The mortality of patients with severe drug eruption, drug hypersensitive history, CD4+ T cell count ≤200 cells/μL, opportunistic infection, viral load ≥1 × 102 copies/mL, low ALB level or decreased RBC and Hb was significantly increased. This evidence concerns the gene GSTM1 and Opportunistic infection.